Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-02-14 11:56 am Sale | 13G | RELMADA THERAPEUTICS INC P RLMD | BIOTECHNOLOGY VALUE FUND L P | 0 0% | -1,647,400 (Position Closed) | View |
2023-02-14 11:56 am Sale | 13G | COGENT BIOSCIENCES INC COGT | BIOTECHNOLOGY VALUE FUND L P | 984,824 1.4% | -2,129,708 (-68.38%) | View |
2023-02-14 11:53 am Purchase | 13G | CULLINAN ONCOLOGY, INC. CGEM | BIOTECHNOLOGY VALUE FUND L P | 7,509,059 16.4% | 2,139,600 (+39.85%) | View |
2023-02-14 11:53 am Sale | 13G | SYNDAX PHARMACEUTICALS INC SNDX | BIOTECHNOLOGY VALUE FUND L P | 1,451,197 2.1% | -3,480,682 (-70.58%) | View |
2023-02-14 11:50 am Sale | 13G | CALLIDITAS THERAPEUTICS AB SPO CALT | BIOTECHNOLOGY VALUE FUND L P | 6,260,311 10.5% | -1,171,251 (-15.76%) | View |
2023-02-14 11:48 am Purchase | 13G | CALITHERA BIOSCIENCES INC CALA | BIOTECHNOLOGY VALUE FUND L P | 488,367 9.99% | 488,367 (New Position) | View |
2023-02-14 11:47 am Sale | 13G | SPERO THERAPEUTICS INC SPRO | BIOTECHNOLOGY VALUE FUND L P | 0 0% | -3,411,520 (Position Closed) | View |
2023-02-14 11:45 am Sale | 13G | AN2 THERAPEUTICS INC ANTX | BIOTECHNOLOGY VALUE FUND L P | 1,563,963 8.1% | -52,702 (-3.26%) | View |
2023-02-14 11:45 am Purchase | 13G | SUTRO BIOPHARMA INC STRO | BIOTECHNOLOGY VALUE FUND L P | 3,347,946 5.8% | 187,530 (+5.93%) | View |
2023-02-14 11:43 am Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | BIOTECHNOLOGY VALUE FUND L P | 2,302,094 5.6% | 99,779 (+4.53%) | View |
2023-02-14 11:42 am Purchase | 13G | AILERON THERAPEUTICS INC N ALRN | BIOTECHNOLOGY VALUE FUND L P | 236,835 5.2% | 236,835 (New Position) | View |
2023-02-14 11:40 am Sale | 13G | ACLARIS THERAPEUTICS INC ACRS | BIOTECHNOLOGY VALUE FUND L P | 3,276,543 4.9% | -591,500 (-15.29%) | View |
2023-02-13 8:20 pm Sale | 13G | XENON PHARMACEUTICALS INC XENE | BIOTECHNOLOGY VALUE FUND L P | 1,271,243 2% | -3,034,297 (-70.47%) | View |
2023-02-13 8:16 pm Purchase | 13G | VERASTEM, INC. VSTM | BIOTECHNOLOGY VALUE FUND L P | 20,094,466 9.99% | 1,588,308 (+8.58%) | View |
2023-02-13 8:14 pm Purchase | 13G | PIERIS PHARMACEUTICALS INC PIRS | BIOTECHNOLOGY VALUE FUND L P | 7,694,060 9.99% | 287,417 (+3.88%) | View |
2023-02-13 8:09 pm Purchase | 13G | MOLECULAR TEMPLATES INC MTEM | BIOTECHNOLOGY VALUE FUND L P | 5,246,565 9.3% | 1,866,966 (+55.24%) | View |
2023-02-13 6:22 pm Purchase | 13G | OVID THERAPEUTICS INC OVID | BIOTECHNOLOGY VALUE FUND L P | 6,851,051 9.7% | 220,000 (+3.32%) | View |
2023-02-13 6:20 pm Purchase | 13G | LEXICON PHARMACEUTICALS INC CO LXRX | BIOTECHNOLOGY VALUE FUND L P | 16,149,179 8.6% | 1,789,179 (+12.46%) | View |
2023-02-13 6:19 pm Sale | 13G | PROTAGONIST THERAPEUTICS INC C PTGX | BIOTECHNOLOGY VALUE FUND L P | 1,250,000 2.5% | -3,641,945 (-74.45%) | View |
2023-02-13 6:17 pm Purchase | 13G | KURA ONCOLOGY INC KURA | BIOTECHNOLOGY VALUE FUND L P | 3,800,983 5.7% | 253,900 (+7.16%) | View |